Medicine Overview

Indication
Know Medicine, Follow Guideline

Adult Dose
Clinical InformationAdministration Information
Indication: Polycystic ovarian syndrome; Female infertility
Age: Adult
Condition: Initial dose
Dose: Injection (Subcutaneous or Intramuscular) – 150 IU
Frequency: daily
Duration: first 5 days
Note: Adjust subsequent dosing based on clinical monitoring (serum oestradiol levels and vaginal ultrasound); dose adjustments should not be made more frequently than once every 2 days and should be 75-150 units per adjustment; maximum dose: 450 units daily; maximum course of treatment: 12 days; stop treatment when adequate response is obtained.
Indication: Polycystic ovarian syndrome; Female infertility
Age: Adult
Condition: To induce ovulation
Dose: Injection – 5000 to 10,000 units of chorionic gonadotrophin
Frequency: single dose
Note: Given 1-2 days after urofollitropin treatment is completed; urofollitropin treatment may be tried again in future cycles.

Child Dose
Clinical InformationAdministration Information
Age: Pediatric
Dose: Safety and efficacy not established
Note: Safety and efficacy not established
Administration
  • Give as subcutaneous injection
  • Rotate injection sites
Side Effect

Drug Interaction
Drug NameRisk Factors
Drugs with luteinising hormone activity
Increased risk of ovarian hyperstimulation syndrome

Disease Interaction
Disease NameRisk Factors
Ovarian cysts not from PCOS
Risk of cyst complications
Primary ovarian failure
Treatment ineffective

Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.